Background and ObjectivesImportant sex differences exist in tau pathology along the Alzheimer disease (AD) continuum, with women showing enhanced tau deposition compared with men, especially during the mild cognitive impairment (MCI) phase. This study aims to identify specific genetic variants associated with sex differences in regional tau aggregation, as measured with PET.MethodsFour hundred ninety-three participants (women, n = 246; men, n = 247) who self-identified as White from the AD Neuroimaging Initiative study, with genotyping data and18F-Flortaucipir tau PET data, were included irrespective of clinical diagnosis (cognitively normal [CN], MCI, and AD). We focused on the genetic variants within 10 genes previously shown to have sex-dependent effects on AD to reduce the burden of multiple comparisons:BIN1,MS4A6A,DNAJA2,FERMT2,APOC1,APOC1P1,FAM193B,C2orf47,TYW5, andCR1.Multivariate analysis of variance was applied to identify genetic variants associated with tau PET data in 3 regions of interests (composite regions of Braak I, Braak III/IV, and Braak V/VI stages) in women and men separately. We controlled for age, scanner manufacture, amyloid status,APOEε4 carriership, diagnosis (CN vs MCI vs AD), and the first 10 genetic principal components to adjust for population stratification.ResultsWe identified 3 genetic loci within 3 different genes associated with tau deposits specifically in women: rs79711283 withinDNAJA2, rs113357081 withinFERMT2, and rs74614106 withinTYW5. In men, we also identified 3 loci withinCR1associated with tau deposits: rs115096248, rs113698814, and rs78150633.DiscussionOur findings revealed sex-specific genetic variants associated with tau deposition independent ofAPOEε4, amyloid status, and clinical diagnosis. These results provide potential molecular targets for understanding the mechanism of sex-specific tau aggregation and developing sex-specific gene-guided precision prevention or therapeutic interventions for AD.